These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9145901)

  • 1. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.
    Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 1997 May; 41(5):1196-202. PubMed ID: 9145901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.
    Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 1998 Sep; 42(3):297-301. PubMed ID: 9786468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity of RU-66647, a new ketolide.
    Jones RN; Biedenbach DJ
    Diagn Microbiol Infect Dis; 1997; 27(1-2):7-12. PubMed ID: 9127099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004.
    Jamjian C; Biedenbach DJ; Jones RN
    Antimicrob Agents Chemother; 1997 Feb; 41(2):454-9. PubMed ID: 9021207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria.
    Malathum K; Coque TM; Singh KV; Murray BE
    Antimicrob Agents Chemother; 1999 Apr; 43(4):930-6. PubMed ID: 10103202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents.
    Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Mar; 42(3):624-30. PubMed ID: 9517943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status.
    Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 1998 Jun; 41(6):649-53. PubMed ID: 9687104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents.
    Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 May; 41(5):1033-6. PubMed ID: 9145864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens.
    Denis A; Agouridas C; Auger JM; Benedetti Y; Bonnefoy A; Bretin F; Chantot JF; Dussarat A; Fromentin C; D'Ambrières SG; Lachaud S; Laurin P; Le Martret O; Loyau V; Tessot N; Pejac JM; Perron S
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3075-80. PubMed ID: 10560728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK.
    Johnson AP; Henwood CJ; Tysall L; Warner M
    Int J Antimicrob Agents; 2001 Jul; 18(1):73-6. PubMed ID: 11463530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
    Credito KL; Ednie LM; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2027-31. PubMed ID: 10428930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2138-40. PubMed ID: 9687424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus influenzae.
    Rospide MF; Biedenbach DJ; Jones RN
    Int J Antimicrob Agents; 2001 Jun; 17(6):451-5. PubMed ID: 11397614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci.
    Barry AL; Fuchs PC; Brown SD
    Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):494-7. PubMed ID: 11561807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.
    Reinert RR; Bryskier A; Lütticken R
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1509-11. PubMed ID: 9624505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae.
    Barry AL; Fuchs PC; Brown SD
    Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):767-9. PubMed ID: 9405952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens.
    Soriano F; Fernández-Roblas R; Calvo R; García-Calvo G; Pardeiro M; Bryskier A
    J Antimicrob Chemother; 1998 Nov; 42(5):647-9. PubMed ID: 9848450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole.
    Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 May; 41(5):1037-41. PubMed ID: 9145865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bactericidal activities of HMR 3004, HMR 3647 and erythromycin against gram-positive bacilli and development of resistance.
    Fernández-Roblas R; Calvo R; Esteban J; Bryskier A; Soriano F
    J Antimicrob Chemother; 1999 Feb; 43(2):285-9. PubMed ID: 11252337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species.
    Jalava J; Kataja J; Seppälä H; Huovinen P
    Antimicrob Agents Chemother; 2001 Mar; 45(3):789-93. PubMed ID: 11181362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.